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Modulation by Nitric Oxide of Cerebral Neutrophil Accumulation After Transient Focal Ischemia in Rats
Sophie Batteur-Parmentier, Isabelle Margaill, and Michel Plotkine Laboratoire de Pharmac% gie, Universite Rene Descartes, Paris, France Summary: A beneficial role of nitric oxide (NO) after cere bral ischemia has been previously attributed to its vascular effects. Recent data indicate a regulatory role for NO in initial leukocyte-endothelial interactions in the cerebral microcircu lation under basal and ischemic conditions. In this study, the authors tested the hypothesis that endogenous NO production during and/or after transient focal cerebral ischemia can also be neuroprotective by limiting the process of neutrophil infiltra tion and its deleterious consequences. Male Sprague-Dawley rats were subjected to 2 hours occlusion of the left middle cerebral artery and the left common carotid artery. The effect of N G -nitro-L-arginine methyl ester (L-NAME) (10 mg/kg, intra peritoneally), an NO synthase inhibitor, was examined at 48 hours after ischemia on both infarct size and myeloperoxidase Accumulating evidence suggests that the postischemic influx of neutrophils can contribute to tissue damage in animal models of focal cerebral ischemia-reperfusion (Hartl et aI., 1996) . Previous investigations have shown progressive neutrophil adherence and infiltration into the brain parenchyma hours to days after the initial insult (Barone et aI., 1995; Matsuo et aI., 1994; Zhang et a!., 1994a) . Moreover, strategies that either reduce circulat ing neutrophils or inhibit neutrophil adhesion to the vas cular endothelium significantly reduce the infarct vol ume produced by transient occlusion of the middle ce rebral artery (Chen et aI., 1992; Chopp, 1995; Matsuo et aI., 1994; Zhang et aI., 1994 Zhang et aI., , 1995 .
Nitric oxide (NO), a well-known modulator of tissue blood flow, platelet aggregation, and microvascular permeability (Cooke and Dzau, 1997) may also be an activity, an index of neutrophil infiltration. L-NAME given 5 minutes after the onset of ischemia increased the cortical infarct volume by 34% and increased cortical myeloperoxidase activ ity by 60%, whereas administration of L-NAME at I, 7, and 22 hours of reperfusion had no effect. Such exacerbations of in farction and myeloperoxidase activity produced when L-NAME was given 5 minutes after the onset of ischemia were not ob served in rats rendered neutropenic by vinblastine. These re sults suggest that after transient focal ischemia, early NO production exerts a neuroprotective effect by modulating neu trophil infiltration. Key Words: Cerebral ischemia-Neu trophil-N G -nitro-L-arginine methylester-Nitric oxide Reperfusion.
endogenous regulator of neutrophil-endothelial cell in teractions (Kubes et aI., 1991) . In models of focal cere bral ischemia, previous studies have shown that inhibi tion of NO synthase (NOS) with N G -nitro-L-arginine methyl ester (L-NAME) administered at high doses and/ or at early stages after ischemia caused an increase in infarct size, suggesting that NO can play a beneficial role (Kuluz et aI., 1993; Margaill et aI., 1997; Zhang and Iadecola, 1993) . Since these first experiments, it has been established that NO produced by the constitutive endo thelial NOS (eNOS) has a protective role. Indeed, mice lacking the gene for eNOS subjected to focal ischemia exhibit a larger infarction than the corresponding wild-type mice (Huang et aI., 1995 (Huang et aI., , 1996 . Accordingly, vasodilator NO donors such as L-arginine, isosorbide dinitrate, sodium nitroprusside, and 3-morpholino sydnonimine have been shown to attenuate ischemic brain injury (Buisson et aI., 1992; Morikawa et aI., 1992; ladecola, 1993, 1994) . However, the precise mechanisms by which endogenous NO can reduce the infarction produced by middle cerebral artery (MCA) occlusion remain to be clarified. Data from extracerebral tissues have shown that L-NAME in models of hepatic (Liu et aI., 1998) and myocardial (Hoshida et aI., 1995) ischemia-reperfusion promoted both neutrophil accumu-[ation and tissue damage, which suggests that NO is ben eficial by modulating neutrophil-mediated injury. In the cerebral microcirculation, it has been shown that inhibi tion of NOS under baseline conditions (Gidday et aI., 1998) , after leukocyte activation by L TB4 (Lindauer et aI., 1996) , or after forebrain ischemia in rats (Hudetz et aI., 1999) resulted in an increase in leukocyte endothelium interactions. Moreover, NO donors after ce rebral asphyxia in piglets decreased leukocyte adhesion (Gidday et aI., 1998) . These studies provide insights into the control of leukocyte-endothelium interactions by NO in cerebral tissues under nonischemic or ischemic conditions.
In the present study, we hypothesized that after tran sient focal cerebral ischemia, endogenous NO production might be beneficial by reducing neutrophil infiltration of the reperfusion period. For this purpose, L-NAME was administered intraperitoneally at 10 mg/kg, a dosage pre viously demonstrated to be deleterious in our laboratory (Margaill et aI., 1997) . Because NO may exert its effect not only during ischemia but also during reperfusion, L-NAME was administered at different time points after ischemia. In a second set of experiments, L-NAME was injected in neutropenic rats to evaluate the contribution of neutrophils.
METHODS
All chemicals were purchased from Sigma Chemical Corp. (Saint Quentin, Fallavier, France) unless otherwise specified. All experiments were performed with male Sprague-Dawley rats (300 to 350 g) in accordance with NIH and French De partment of Agriculture guidelines (license no. 01352).
Transient focal cerebral ischemia
Rats were anesthetized with chloral hydrate (400 mg/kg, given intraperitoneally) and allowed to breathe spontaneously. The left MCA was exposed by means of a temporal craniotomy and occluded with a microclip (IS x 0.4 mm; Ohwa Tsuho Co., Tokyo, Japan), and the left common carotid artery (CCA) was concomitantly clamped. The microclip was placed on the MCA at a site proximal to the lenticulostriate artery to induce both cortical and striatal infarction. Two hours after induction of ischemia, rats were reanesthetized, the microclip occluding the MCA was removed, and CCA circulation was restored. Reper fusion in both arteries was checked under a microscope within the first 5 minutes after clip removal. During the surgical pro cedure and until recovery from anesthesia (2 hours after the onset of reperfusion), body temperature was maintained at 37"C to 38°C by means of a heating blanket. Sham-operated rats underwent the same surgical procedure, but the MCA and the CCA were not occluded. After surgery, rats were returned to their cage. Animals with feeding difficulties were fed with mashed laboratory chow.
Forty-eight hours after ischemia, the animals were killed with an overdose of sodium pentobarbitone and immediately perfused transcardially with 200 mL isotonic saline at 25DC with a pressure of 100 mm Hg to t1ush all blood components from the vasculature. Brains were removed and sliced into seven 2-mm-thick coronal sections using a brain matrix for the rat. In the fourth section, the infarcted cortical tissue was iso-lated, frozen, and stored at -40°C for myeloperoxidase deter mination (see below). A similar segment was isolated from sham-operated rats. The six remaining sections were used to quantify infarct volume as follows.
Measurement of infarct volume
Coronal brain sections were immersed in 2% 2,3,5triphenyltetrazolium chloride, incubated for 20 minutes at 20DC, and then placed in formalin for one night in the dark. The striatal and cortical areas of infarction were measured on each section using an image analyzer (1m star, Paris, France). Be cause the fourth section was used for the myeloperoxidase as say, the cortical and striatal infarct areas corresponding to this section were read on the back of the third section. The distance between coronal sections was used to calculate a linear inte gration for striatal and cortical infarct volumes. Infarct volumes were corrected for brain edema according to Golanov and Reis (1995) .
Evaluation of neutrophil infiltration
Myeloperoxidase activity was used as an index of neutrophil accumulation and determined as previously described by Bar one et al. (1991) . Frozen tissue samples were quickly weighed and homogenized (Ultra-Turrax, IKA Labortechnik, Germany) in 20 volumes of 5 mmollL potassium phosphate buffer (4°C, pH 6) followed by centrifugation at 30,000 g (30 minutes at 4°C). The supernatant was discarded and the pellet was washed again as described above. After decanting the supernatant, the pellet was extracted by suspending it in 10 volumes of 0.5% hexadecyltrimethylammonium bromide dissolved in 50 mmollL potassium phosphate buffer (25°C, pH 6). The samples were immediately frozen in isopentane at -40°C, and three freezelthaw and sonication (10 seconds) cycles were per formed. After the last sonication, samples were incubated at 4 DC for 20 minutes and centrifuged at 15,500 g (15 minutes at 4DC). Myeloperoxidase activity in the supernatant was assayed as described by Bradley et al. (1982) . Briefly, 0.1 mL super natant was mixed with 2.9 mL 50 mmol/L potassium phosphate buffer containing 0.167 mg o-dianisidine dihydrochloride and 0.0005% hydrogen peroxide. The change in absorbance at 460 nm was measured at IS-second intervals for 2 minutes with a spectrophotometer (Milton Roy; Rochester, NY, U.S.A.). One unit (U) of myeloperoxidase activity was defined as the amount that degraded 1 /-Lmol hydrogen peroxide per minute at 25°C, and was normalized on the basis of wet weight tissue (U/g wet weight).
Determination of regional cerebral blood flow
Rats were anesthetized with chloral hydrate (400 mg/kg, given intraperitoneally) and placed on a stereotactic frame (David Kopf; Rouchaire, Courtaboeuf, France). The skull was exposed and a hole 2.5 mm in diameter was drilled in the left side at a site 3 mm lateral to the midline and 4.2 mm anterior to the interaural line. These cortical coordinates represented the ischemic penumbra of the infarct. To determine changes in regional cerebral blood flow (rCBF), a laser-Doppler t10wmeter (BPM2, Vasamedics; Saint Paul, MN, U.S.A.) with a 2-mm probe (P435, Vasamedics) was used. The probe tip was posi tioned above the intact dural surface and fixed on a support attached to the skull. Rats were then prepared for MCA and CCA occlusions as described above. Once a stable rCBF was obtained, rats underwent ischemia. rCBF was recorded 5, 15, 30, and 120 minutes after the occlusion and 15 and 30 minutes after the reperfusion. Data are presented as percentage of preischemic rCBF.
Experimental protocols
Experiment I: Time-dependent effects of L-NAME. This ex periment was undertaken to determine whether the deleterious effect of L-NAME was related to the time of injection after ischemia and reperfusion. Rats were assigned to six groups: a sham-operated group (n = 4), an ischemic group treated with the vehicle of L-NAME (distilled water, n = 10), and four groups of ischemic rats treated with L-NAME (10 mg/kg, given intraperitoneally) given 5 minutes after the onset of ischemia (n = 11), or after I hour (n = 9), 7 hours (n = 7), or 22 hours (n = 10) of reperfusion. Animals were killed after 46 hours of reperfusion, and myeloperoxidase activity and brain infarction were determined as described above.
Experiment 2: Effe ct of L-NAME in neutropenic rats. The effect of L-NAME (10 mg/kg, given intraperitoneally 5 minutes after the onset of ischemia) was examined in neutropenic rats. Neutropenia was induced by vinblastine administration, as de scribed previously by Uhl et al. (1993) . For this purpose, ani mals were anesthetized with chloral hydrate (400 mg/kg given intraperitoneally), and their tail veins were cannulated for in jections of vinblastine sulfate (0.5 mg/kg) or its vehicle (sa line). This dose of vinblastine was shown to result in a maxi mum reduction in neutrophil count starting on day 4 after in jection and persisting for at least 2 days (Parmentier, unpublished observation) . To prevent infection, benzathine benzylpenicillin (Specia; Rhone Poulenc Rorer, Montrouge, France) (300,000 U/kg) and gentamicin (Schering-Plough; Levallois-Perret, France) (10 mg/kg) were given intramuscu larly concomitantly with vinblastine administration and again just before the onset of ischemia. Ischemia was performed 4 days after vinblastine injection. Blood samples were taken just before ischemia, and leukocyte counts were performed manu ally with a hemocytometer and May-GrUnwald Giemsa-stained smears.
Rats were then further divided into four groups:
• Group 1: vehicle of vinblastine and vehicle of L-NAME (n = 9)
• Group 2: vehicle of vinblastine and L-NAME (n 8)
• Group 3: vinblastine and L-NAME (n = 9) • Group 4: vinblastine and vehicle of L-NAME (n 7).
Animals were killed at 46 hours of reperfusion, and my eloperoxidase activity and brain infarction were determined as described above. Myeloperoxidase activity was concomitantly determined in sham-operated rats (n = 6).
Experiment 3: Effect of L-NAME on reBF and physiologic variables. rCBF was recorded in rats subjected to ischemia and treated with either L-NAME (10 mg/kg, given intraperitoneally, n = 5) or its vehicle (n = 5) given 5 minutes after the onset of ischemia. In a parallel group of anesthetized rats, the tail artery was cannulated to monitor mean arterial blood pressure, arterial oxygen tension (Pao2), arterial carbon dioxide tension (Paco2), and pH. Mean arterial blood pressure was recorded before ischemia, 30 minutes after the onset of ischemia, and 30 minutes after the onset of reperfusion. At the same time, arterial blood gases and pH were measured with a blood gas analyzer (Model ABL 330; Radiometer, Copenhagen, Denmark), and rectal temperature was monitored and maintained at 37°C to 38°C by means of a heating blanket. Physiologic variables were assessed in ischemic animals receiving either L-NAME (10 mg/kg, given intraperitoneally, n = 5) or its vehicle (n = 5) at 5 minutes after the onset of ischemia.
Data expression and statistical analysis
Data are expressed as mean ± standard deviation. Compari sons between two groups were evaluated by a two-tailed un-
paired Student's t-test. Comparisons between multiple groups were evaluated by analysis of variance, and subsequent group comparisons were carried out by the protected least significant difference Fisher's test. Differences were considered statisti cally significant at a value of P < 0.05.
RESULTS
Experiment 1: Time-dependent effects of L-NAME In vehicle-treated rats, the transient occlusion of the left MCA and CCA caused infarcts involving the cere bral cortex and the striatum at 2 days of reperfusion (110 ± 48 mm 3 and 44 ± 14 mm 3 ; respectively) ( Fig. lA) . When injected 5 minutes after the onset of ischemia, L-NAME increased the cortical infarction by 34% (147 ± 50 mm 3 vs. llO ± 48 mm 3 in vehicle-treated rats, P < 0.05) but did not modify the striatal lesion size (49 ± 3 mm 3 versus 44 ± 14 mm 3 in vehicle-treated rats, P > 0.05). The more delayed treatments with L-NAME at ], 7, or 22 hours of reperfusion did not significant] y change the infarct volumes in the cortex and in the striatum (see Fig. IA ).
Two days after ischemia, there was a massive increase in cortical myeloperoxidase activity in vehicle-treated rats compared with sham-operated rats (0.27 ± 0.11 vs. 0.0 1 ± 0.0 1 U/g wet weight; P < 0.0 1) (see Fig. IB ). ter (L-NAME) on (A) infarct volumes and (8) myelopemxidase activity (mean ± SO) 48 hours after transient focal cerebral isch emia. A single injection of L-NAME (10 mg/kg, given intraperito neally) was given either at 5 minutes after the onset of ischemia or after 1,7, or 22 hours of reperfusion. n.s., not significant; *P < 0.05; ** P < 0.01 vs. vehicle-treated rats. (8) myeloperoxidase activity (mean ± SO) in neutropenic rats 48 hours after transient focal cerebral ischemia. Rats were rendered neutropenic by vinblastine (0.5 mg/kg, given intravenously) given 4 days before ischemia. L NAME (10 mg/kg, given intraperitoneally) was injected at 5 min utes after the onset of ischemia. n.s., not significant; * P < 0.05; **P < 0.01 vs. vehicle-treated rats. Neutropenic rats treated with L-NAME had smaller cortical infarct volumes ( tt P < 0.01) and lower myeloperoxidase activity levels ( t tt P < 0.001) than rats treated with L-NAME alone.
When L-NAME was given 5 minutes after the onset of ischemia, the normal increase in myeloperoxidase activ ity induced by ischemia was significantly increased by 60% (0.43 ± 0.19 vs. 0.27 ± 0.11 U/g wet weight in vehicle-treated rats; P < 0.05). Delayed treatments after 1, 7, or 22 hours of reperfusion had no effect on my eloperoxidase activity (see Fig. IB ).
Experiment 2: Effect of L-NAME in neutropenic rats Four days after its injection, vinblastine reduced cir culating neutrophils (0.50 ± 0.50 x lO 'I /L vs. l.80 ± 0.60
x 10 9 /L in saline-treated rats; P < 0.(01), but the mono nuclear cells (monocytes and lymphocytes) remained un changed (4.60 ± 1.70 x 10 9 /L vs. 5.48 ± 1.24 x 10 9 /L in saline-treated rats; P > 0.(5).
The effect of L-NAME on infarct volumes in vinblas tine-treated rats is shown in Fig. 2A . Ischemic rats treated by both the vehicles of L-NAME and vinblastine showed a cortical and striatal infarction at 2 days of reperfusion (109 ± 33 mm 3 and 34 ± 4 mm 3 , respec tively). Vinblastine treatment decreased the cortical in-farct volume by 42% (63 ± 37 mm 3 vs. 109 ± 33 mm 3 in vehicle-treated rats; P < 0.(5). In contrast, L-NAME given at 5 minutes after the onset of ischemia markedly increased the cortical infarction by 67% (182 ± 73 mm 3 vs. 109 ± 33 mm 3 in vehicle-treated rats; P < 0.01) . However, when L-NAME was injected with the same protocol in vinblastine-treated rats, no increase in the cortical infarction was observed (99 ± 33 mm 3 vs. 109 ± 33 mm 3 in vehicle-treated rats; P > 0.(5). None of the treatments modified the striatal infarct volume.
In the same rats, cortical myeloperoxidase activity was assessed (see Fig. 2B ). Vehicle-treated rats exhibited a massive increase in myeloperoxidase activity at 2 days after ischemia compared with sham-operated rats (0.27 ± 0.02 vs. 0.04 ± 0.01 U/g wet weight; P < 0.(01). This increase in myeloperoxidase activity induced by isch emia was reduced by 52% in vinblastine-treated rats (0.13 ± 0.06 vs. 0.27 ± 0.02 U/g wet weight in vehicle treated rats; P < 0.(1), but it was exacerbated by 48% in L-NAME-treated rats (0.40 ± 0.12 vs. 0.27 ± 0.02 U/g wet weight in vehicle-treated rats; P < 0.0 I). However, in vinblastine-treated rats, L-NAME treatment did not affect myeloperoxidase activity (0.15 ± 0.09 vs. 0.13 ± 0.06 U/g wet weight in vinblastine-treated rats; P > 0.(5). In the vehicle-treated rats, occlusion of the arteries induced a rapid reduction in rCBF to 61 % ± 3% of preischemic values, which persisted during the 2-hour period of ischemia (Fig. 3) . Clip removal produced a progressive increase in rCBF, which was significant after 30 minutes of reperfusion (74% ± 8% vs. 53% ± 6% just before reperfusion, P < 0.(5). L-NAME injected 5 min utes after the onset of occlusion did not modify the rCBF time course during either the ischemic period (59% ± 3% of preischemic values) or the first 30 minutes of reper- Effect of 2 hours of ischemia and reperfusion on regional cerebral blood flow (rCBF) (mean ± SO) in rats treated with ve hicle and NG-NITRo-L-arginine methyl ester (L-NAME). L-NAME (10 mg/kg, given intraperitoneally) or its vehicle was injected at 5 minutes after the onset of ischemia. There was no significant difference between the two groups.
fusion (83% ± 9% at 30 minutes of reperfusion). The mean arterial blood pressure, arterial blood gases, pH, and rectal temperature remained within the normal physiologic range before ischemia, during ischemia, and after reperfusion (Table I) . L-NAME did not modify the ses values during ischemia and after reperfusion.
DISCUSSION
Our results demonstrate that administration of the NOS inhibitor L-NAME during the early stage of the 2-hour ischemic period expands brain infarction and in duces a significant enlargement of the cerebral neutro phil content at 2 days of reperfusion. Both these effects of L-NAME are totally suppressed in rats rendered neu tropenic by vinblastine. Thus, endogenous NO seems to play a beneficial role after transient focal cerebral isch emia by limiting the deleterious effect of neutrophil in filtration into the brain tissues.
A neuroprotective role for NO has been previously demonstrated in models of focal cerebral ischemia by an increase in infarct volumes after early and/or high dosage of NOS inhibitors (Kuluz et aI., 1993; Margaill et aI., 1997; Zhang and Iadecola, 1993) ; an expansion of the lesion size in eNOS knockout mice (Huang et a!., 1995 (Huang et a!., , 1996 ; and a reduction in ischemic damage after treat ment with L-arginine supplementation or NO donors (Buisson et aI., 1992; Morikawa et a!., 1992; ladecola, 1993, 1994) . This beneficial effect has been previously attributed to the vasodilatory properties of NO-more specifically, to an increase in cerebral blood flow during the ischemic period (Morikawa et aI., 1994; Zhang and Iadecola, 1993) . In our study, it is unlikely that L-NAME enhanced the cerebral infarction by alter ing the cerebral blood flow or the arterial blood pressure, because these variables did not differ among the two groups of vehicle-treated and L-NAME-treated rats dur ing ischemia and reperfusion. These results are not in accordance with those of previous studies showing that L-NAME induces hypertension and hypoperfusion throughout the brain under basal conditions (Dawson et aI., 1993; Kelly et a!., 1995) and after global and fore brain ischemia (Humphreys and Koss, 1998; . It is, however, noticeable that these studies used higher doses of L-NAME or intravenous injection, which is a more sensitive way to induce vascular changes than intraperitoneal injection.
There is considerable evidence that cerebral ischemia reperfusion leads to a progressive increase in neutrophil adherence and infiltration that contributes to the devel opment of ischemic brain damage (Hartl et aI., 1996) . In our study, the determination of myeloperoxidase activity, an enzyme marker of neutrophils, was used to quantify neutrophil infiltration. This method has been shown to indicate indirectly but precisely significant accumulation of neutrophils into cerebral tissues after ischemia (Bar one et a!., 199 1). In our model, we observed a significant increase in myeloperoxidase activity in the infarcted cor tical tissues, indicating significant neutrophil infiltration after 2 days of reperfusion. Moreover, we showed a sig nificant reduction in the cortical infarct size in neutrope nic rats. Taken together, these data support an injurious role for neutrophils in our model of transient focal cere bral ischemia. Kubes et aI. (199 1) first revealed the role of NO in the regulation of leukocyte-endothelial interactions in non cerebral tissues. They demonstrated that impairment of endothelial NO production in mesenteric venules leads to a drastic increase in leukocyte adherence to the vascular endothelium. From this initial result, other researchers have reported that inhibition of NOS can promote neu trophil-endothelial adherence in peripheral vascular beds under basal and ischemic conditions (Harbrecht et aI., 1992; Ma et aI., 1993; Persson et aI., 1990) . Moreover, NOS inhibition in models of peripheral ischemia reperfusion exacerbates the tissue damage and increases neutrophil accumulation (Kupatt et a!., 1997; Liu et aI., 1998; Naito et aI., 1998; Sato et aI., 1997; Tavaf Montamen et aI., 1998) . The NO-dependent mechanisms regulating leukocyte-endothelial adherence under basal and ischemic conditions may include the capacity of NO to influence the steady state of the superoxide anion, a Physiologic variables and rectal temperature were recorded just before ischemia (preischemia), 30 minutes after the onset of ischemia (ischemia) and 30 minutes after the onset of reperfusion (postischemia). L-NAME (10 mg kg-' , intraperitoneally) was injected 5 minutes after ischemia induction. Physiologic variables and rectal temperature did not differ between groups (P > 0.05) .
.I Cereb Blood Flow Metab. Vol. 20. No. 5. 2000 well-established proadherent agent (Clancy et aI., 1992; Rubanyi et aI., 1991; Seth et aI., 1994; Suematsu et aI., 1994) , and the reduction of the expression of adhesion molecules (De Caterina et aI., 1995; Gauthier et aI., 1994; Khan et a1., 1996) .
In the cerebral circulation, after the initial observation of Lindauer et a1. (1996) that NOS inhibition during leu kocyte activation (by LTB4) enhances leukocyte adher ence, two other studies have investigated the effects of NOS inhibition on leukocyte adherence during cerebral ischemia-reperfusion. They have reported that superfu sion of NO donors (sodium nitroprusside) into the pial vasculature reduces the leukocyte adherence induced by asphyxia in piglets (Gidday et aI., 1998) and that L NAME (20 mg/kg, given intravenously) augments leu kocyte adherence induced by forebrain ischemia in rats (Hudetz et aI., 1999) . Taken together, these studies indi cate a role for NO in modulating leukocyte-endothelial adherence in the cerebral circulation under hypoxic and ischemic conditions. However, these studies examined only the effect of NO on leukocyte-endothelial interac tions in the pial circulation during the initial hours of postischemic reperfusion (1 or 2 hours). Thus, the time course of the NO-based anti adherent effect after isch emia and reperfusion remains to be established. More over, the suppression of NO-based antiadherent effects might lead to an additional increase in tissue damage produced after cerebral ischemia, as has been described after peripheral ischemia (Kupatt et a1., 1997; Liu et aI., 1998; Naito et aI., 1998; Sato et aI., 1997; Tavaf Montamen et aI., 1998) . This led us to investigate in our neutrophil-dependent model of transient focal ischemia whether L-NAME might exacerbate cerebral infarction by increasing neutrophil infiltration, and whether the time of administration of L-NAME relative to the onset of ischemia was relevant. Neutrophil infiltration and ce rebral infarction were examined at 2 days of reperfusion, which corresponds to a much later time than in the stud ies using peripheral ischemia (generally performed at 2 to 6 hours of reperfusion). This time can be justified by the fact that full development of cerebral infarction is delayed after cerebral ischemia (1 to 2 days), and neu trophil infiltration occurs much later after cerebral isch emia (1 to 2 days) (Barone et aI., 1995; Matsuo et aI., 1994; Zhang et aI., 1994a) than after peripheral ischemia (6 hours to 1 day) (Smith et aI., 1988; Suzuki and To ledo-Pereyra, 1994) . The reasons for this delay in neu trophil infiltration after cerebral ischemia remain to be clarified; they might, however, include a late opening of the blood-brain barrier (Belayev et aI., 1996) . In our study, L-NAME at a dosage that increases infarction en hanced the cerebral neutrophil accumulation at 2 days after ischemia. Both these effects are not observed in neutropenic rats. These results indicate for the first time that NOS inhibition induces a leukocyte-dependent in-crease in ischemic brain damage after transient focal ischemia.
Our data also demonstrated that the effect of L-NAME on the regulation of cerebral neutrophil accumulation is time-dependent and occurs within the first 3 hours after ischemia. This suggests an early and transient production of NO after focal ischemia, and such a production has indeed been well documented (Iadecola, 1997; Kader et aI., 1993) . The source responsible for this NO production is likely to be the constitutive isoform(s) of NOS, be cause we have previously reported that the inducible iso form of NOS appears after 24 hours of reperfusion in our model (Parmentier et a1., 1999) . Accordingly, a recent study has shown that mice lacking the gene for eNOS or for neuronal NOS exhibit an increase in neutrophil roll ing and adherence in the mesentery under baseline con ditions (Lefer et aI., 1999) . Therefore, the transient effect of L-NAME observed in our model might be explained by the fact that endogenous NO produced by the consti tutive isoforms of NOS is rapidly impaired after isch emia. Another possible explanation might be that NO acts on neutrophil-endothelial interactions by means of the reduction of the expression of the adhesion mol ecules, which occurs early and transiently after ischemia.
The role of NO in modulating postischemic neutrophil infiltration demonstrated in the present study may ex plain, in part, the findings that brain infarction is larger in endothelial NOS knockout mice (Huang et aI., 1995 (Huang et aI., , 1996 and after early administration of nonselective NOS inhibitors (Kuluz et aI., 1993; Margaill et aI., 1997; Zhang and Iadecola, 1993) . This can also explain the neuroprotective role of L-arginine supplementation and NO donors (Buisson et aI., 1992; Morikawa et aI., 1992) . In summary, this study provides the first evidence that blocking the acute production of NO aggravates brain damage in a model of transient focal cerebral ischemia by promoting neutrophil accumulation in the ischemic tissues. Thus, during the initial phase after focal isch emia, the antiinflammatory effects of NO exceed its cy totoxic effects, providing a theoretical basis for NO based therapies in the treatment of focal cerebral isch emia-reperfusion.
